About Globe Life Inc.
https://www.globelifeinsurance.comGlobe Life Inc., through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle to middle income households in the United States. The company operates through four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.
CEO
Frank Martin Svoboda
Compensation Summary
(Year 2023)
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2014-07-02 | Forward | 3:2 |
| 2013-05-15 | Reverse | 1:10 |
ETFs Holding This Stock
Summary
Showing Top 3 of 377
Ratings Snapshot
Rating : A
Most Recent Analyst Grades
TD Cowen
Buy
Truist Securities
Buy
Keefe, Bruyette & Woods
Outperform
Morgan Stanley
Overweight
Wells Fargo
Overweight
JP Morgan
Overweight
Grade Summary
Showing Top 6 of 8
Price Target
Institutional Ownership
VANGUARD GROUP INC
Shares:10M
Value:$1.39B
BLACKROCK INC.
Shares:6.1M
Value:$847.98M
BLACKROCK, INC.
Shares:5.71M
Value:$793.3M
Summary
Showing Top 3 of 792
About Globe Life Inc.
https://www.globelifeinsurance.comGlobe Life Inc., through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle to middle income households in the United States. The company operates through four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $1.51B ▲ | $147.7M ▲ | $387.84M ▲ | 25.63% ▲ | $4.81 ▲ | $513.24M ▲ |
| Q2-2025 | $1.48B ▲ | $143.18M ▼ | $252.75M ▼ | 17.06% ▼ | $3.09 ▲ | $348.18M ▼ |
| Q1-2025 | $1.48B ▲ | $143.74M ▼ | $254.56M ▼ | 17.2% ▼ | $3.05 ▲ | $351.07M ▲ |
| Q4-2024 | $1.47B ▲ | $155.01M ▲ | $255.2M ▼ | 17.4% ▼ | $3.04 ▼ | $348.13M ▼ |
| Q3-2024 | $1.46B | $136.26M | $302.99M | 20.82% | $3.45 | $408.35M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $18.16B ▲ | $30.53B ▲ | $24.84B ▲ | $5.69B ▲ |
| Q2-2025 | $17.72B ▼ | $29.81B ▲ | $24.39B ▲ | $5.42B ▼ |
| Q1-2025 | $17.87B ▲ | $29.71B ▲ | $24.28B ▲ | $5.43B ▲ |
| Q4-2024 | $17.41B ▼ | $29.08B ▼ | $23.77B ▼ | $5.31B ▲ |
| Q3-2024 | $18.57B | $29.56B | $24.92B | $4.64B |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $0 | $305.98M ▼ | $-73.79M ▼ | $-171.79M ▲ | $63.59M ▲ | $208.69M ▼ |
| Q2-2025 | $0 ▼ | $307.93M ▼ | $-64.03M ▲ | $-230.78M ▼ | $6.85M ▼ | $294.99M ▼ |
| Q1-2025 | $254.56M ▼ | $431.89M ▲ | $-239.95M ▼ | $-124.46M ▲ | $66.94M ▲ | $420.14M ▲ |
| Q4-2024 | $255.2M ▼ | $336.93M ▼ | $181.37M ▲ | $-500.95M ▼ | $30.78M ▼ | $321.93M ▲ |
| Q3-2024 | $302.99M | $340.59M | $-196.3M | $-95.1M | $46.63M | $311.28M |
Revenue by Products
| Product | Q3-2024 | Q4-2024 | Q1-2025 | Q2-2025 |
|---|---|---|---|---|
 Health Segment | $350.00M ▲ | $710.00M ▲ | $370.00M ▼ | $380.00M ▲ |
 Life Segment | $820.00M ▲ | $1.64Bn ▲ | $830.00M ▼ | $840.00M ▲ |
CEO
Frank Martin Svoboda
Compensation Summary
(Year 2023)
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2014-07-02 | Forward | 3:2 |
| 2013-05-15 | Reverse | 1:10 |
ETFs Holding This Stock
Summary
Showing Top 3 of 377
Ratings Snapshot
Rating : A
Most Recent Analyst Grades
TD Cowen
Buy
Truist Securities
Buy
Keefe, Bruyette & Woods
Outperform
Morgan Stanley
Overweight
Wells Fargo
Overweight
JP Morgan
Overweight
Grade Summary
Showing Top 6 of 8
Price Target
Institutional Ownership
VANGUARD GROUP INC
Shares:10M
Value:$1.39B
BLACKROCK INC.
Shares:6.1M
Value:$847.98M
BLACKROCK, INC.
Shares:5.71M
Value:$793.3M
Summary
Showing Top 3 of 792